Transcriptomes of macrophages in atherosclerotic plaques and peripheral leukocytes from patients with type 2 diabetes were enriched in RUNX1 targets, and targeting RUNX1 provided further evidence for the involvement of RUNX1 in the downstream effects of hyperglycemia-induced trained immunity in macrophages 36. The gene discussed is RUNX1; the disease is Hyperglycemia.